SEC Comment Letter for Silo Pharma, Inc. (SILO) (CIK 0001514183) (SILO) — May 27, 2011
Silo Pharma, Inc. (SILO) (CIK 0001514183)
Date: May 27, 2011 · CIK: 0001514183 · Accession: 0000000000-11-033127
AI Filing Summary & Sentiment
File numbers found in text: 333-173163
Referenced dates: April 27, 2011
Show Raw Text
May 27, 2011 Via E-mail Melvin Schlossberg President & Chief Executive Officer Gold Swap Inc. 72 Pond Road Woodbury, NY 11797 Re: Gold Swap Inc. Amendment No. 1 to Registrati on Statement on Form S-1 Filed May 11, 2011 File No. 333-173163 Dear Mr. Schlossberg: We have reviewed your registration statem ent and have the following comments. In some of our comments, we may ask you to provi de us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comments apply to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your re gistration statement and the information you provide in response to these comments, we may have additional comments. General 1. We note your response to comment one in our letter dated April 27, 2011 as to why you are not a blank check company. Please in clude this analysis in your filing and include a specific business plan for the ne xt twelve months. In disclosing your business plan, also provide a descript ion of your day-to-day operations. 2. We note your response to comment two in our letter dated Ap ril 27, 2011, however, it does not appear that you have revised your we bsites or disclosure accordingly. Please reconcile the information on your websites a nd in your registration statement so that material information about your company is co nsistent. Also revise your disclosure throughout the filing to clarify whether you have commenced operations and to state whether you are doing business under additional names. Melvin Schlossberg Gold Swap Inc. May 27, 2011 Page 2 Prospectus Summary, page 1 The Offering, page 1 3. Please revise tabular net loss and net cash used by operating activities under Going Concern Considerations to reflect fi nancial information through March 31, 2011. Description of Securities, page 16 4. We note your response to comment eight in our letter dated April 27, 2011, that you do not have any charter or byl aw provisions specifying re quisite voting rights. We also note Article 6.10 of your bylaws, filed as exhibit 3.3 to this registration statement which states “[a]ny other action shall be authorized by a majority of the votes cast in favor of or against such action . . . .” Please revise or advise. Liquidity and Capital Resources, page 21 5. We note your response to comment 10 in our letter dated April 27, 2011. As previously requested, provide an approximate timeline as to when you expect to incur the costs listed at the bottom of page 20, and state what you plan to do if you raise some, but not all of the $150,000. Also stat e whether there is a maximum amount of funds that your officers and directors have agreed to le nd. In this regard, we note your statement on page F-9 that your ability to continue as a going concern includes “partial reliance” on rela ted party financing. Certain Relationships and Re lated Transactions, page 25 6. We note your response to comment 13 in our letter dated April 27, 2011, but it does not appear that you revised your disclosure accordingly. Please identify each of your promoters and state the nature and amount of anything of value received or to be received from the company. We urge all persons who are responsible for th e accuracy and adequacy of the disclosure in the filing to be certain that the filing incl udes the information the Securities Act of 1933 and all applicable Securities Act rules require. Since the company and its management are in possession of all facts relating to a company’s disc losure, they are responsible for the accuracy and adequacy of the disclosures they have made. Melvin Schlossberg Gold Swap Inc. May 27, 2011 Page 3 You may contact Milwood Hobbs , Staff Accountant, at (202) 551-3241 or Jim Allegretto, Senior Assistant Chief Accountant, at (202) 551-3849 if you have questions regarding comments on the financial statements and related matters. Please contact Lisa Kohl, Staff Attorney, at (202) 551-3252, Brigitte Lippmann, Special Coun sel, at (202) 551-3713, or me at (202) 551- 3720 with any other questions. Sincerely, /s/ Brigitte Lippmann for H. Christopher Owings Assistant Director cc: David Lubin, Esq. David Lubin & Associates, PLLC